Unknown

Dataset Information

0

Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism.


ABSTRACT: Vesicular stomatitis virus (VSV)-based oncolytic virotherapy has the potential to significantly improve the prognosis of aggressive malignancies such as brain cancer. However, VSV's inherent neurotoxicity has hindered clinical development so far. Given that this neurotropism is attributed to the glycoprotein VSV-G, VSV was pseudotyped with the nonneurotropic envelope glycoprotein of the lymphocytic choriomeningitis virus (LCMV-GP→VSV-GP). Compared to VSV, VSV-GP showed enhanced infectivity for brain cancer cells in vitro while sparing primary human and rat neurons in vitro and in vivo, respectively. In conclusion, VSV-GP has a much wider therapeutic window than VSV and is thus more suitable for clinical applications, especially in the brain.

SUBMITTER: Muik A 

PROVIDER: S-EPMC3094995 | biostudies-literature | 2011 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism.

Muik Alexander A   Kneiske Inna I   Werbizki Marina M   Wilflingseder Doris D   Giroglou Tsanan T   Ebert Oliver O   Kraft Anna A   Dietrich Ursula U   Zimmer Gert G   Momma Stefan S   von Laer Dorothee D  

Journal of virology 20110330 11


Vesicular stomatitis virus (VSV)-based oncolytic virotherapy has the potential to significantly improve the prognosis of aggressive malignancies such as brain cancer. However, VSV's inherent neurotoxicity has hindered clinical development so far. Given that this neurotropism is attributed to the glycoprotein VSV-G, VSV was pseudotyped with the nonneurotropic envelope glycoprotein of the lymphocytic choriomeningitis virus (LCMV-GP→VSV-GP). Compared to VSV, VSV-GP showed enhanced infectivity for b  ...[more]

Similar Datasets

| S-EPMC164684 | biostudies-literature
| S-EPMC4268581 | biostudies-literature
| S-EPMC4262309 | biostudies-literature
| S-EPMC2168972 | biostudies-literature
| PRJNA508804 | ENA
| S-EPMC3735647 | biostudies-literature
| S-EPMC9328903 | biostudies-literature
| S-EPMC114004 | biostudies-literature
| S-EPMC11199562 | biostudies-literature
| S-EPMC262588 | biostudies-literature